These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 17894679

  • 1. Persistency rates for prostaglandin and other hypotensive eyedrops: population-based study using pharmacy claims data.
    Rait JL, Adena MA.
    Clin Exp Ophthalmol; 2007; 35(7):602-11. PubMed ID: 17894679
    [Abstract] [Full Text] [Related]

  • 2. Comparison of the efficacy and safety of latanoprost 0.005% compared to brimonidine 0.2% or dorzolamide 2% when added to a topical beta-adrenergic blocker in patients with primary open-angle glaucoma or ocular hypertension.
    Stewart WC, Sharpe ED, Day DG, Kolker AE, Konstas AG, Lee WH, Rieser JC, Chopra H, Holmes KT.
    J Ocul Pharmacol Ther; 2000 Jun; 16(3):251-9. PubMed ID: 10872922
    [Abstract] [Full Text] [Related]

  • 3. Patient persistency with pharmacotherapy in the management of glaucoma.
    Reardon G, Schwartz GF, Mozaffari E.
    Eur J Ophthalmol; 2003 Jul; 13 Suppl 4():S44-52. PubMed ID: 12948052
    [Abstract] [Full Text] [Related]

  • 4. Persistence and adherence with topical glaucoma therapy.
    Nordstrom BL, Friedman DS, Mozaffari E, Quigley HA, Walker AM.
    Am J Ophthalmol; 2005 Oct; 140(4):598-606. PubMed ID: 16226511
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC, Konstas AG, Nelson LA, Kruft B.
    Ophthalmology; 2008 Jul; 115(7):1117-1122.e1. PubMed ID: 18082886
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA, Renard JP, Cunliffe IA, Rojanapongpun P.
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [Abstract] [Full Text] [Related]

  • 12. Combination therapy as initial treatment in glaucoma and suspected glaucoma.
    Mikelberg FS, Etminan M.
    Can J Ophthalmol; 2012 Jun; 47(3):240-2. PubMed ID: 22687299
    [Abstract] [Full Text] [Related]

  • 13. Hyperemia-associated costs of medication changes in glaucoma patients treated initially with prostaglandin analogs.
    Schwartz GF, Tan J, Kotak S.
    J Ocul Pharmacol Ther; 2009 Dec; 25(6):555-61. PubMed ID: 20028264
    [Abstract] [Full Text] [Related]

  • 14. Comparison of ocular hypotensive effect and safety of brinzolamide and timolol added to latanoprost.
    Miura K, Ito K, Okawa C, Sugimoto K, Matsunaga K, Uji Y.
    J Glaucoma; 2008 Dec; 17(3):233-7. PubMed ID: 18414111
    [Abstract] [Full Text] [Related]

  • 15. New glaucoma medications in the geriatric population: efficacy and safety.
    Novack GD, O'Donnell MJ, Molloy DW.
    J Am Geriatr Soc; 2002 May; 50(5):956-62. PubMed ID: 12028187
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacological advances in the treatment of glaucoma.
    Serle JB.
    Drugs Aging; 1994 Sep; 5(3):156-70. PubMed ID: 7803944
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.